Gill v. bluebird bio, Inc. et al

Track this case

Case overview

Case Number:

1:24-cv-10803

Court:

Massachusetts

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Patti B. Saris

Firms

Companies

Sectors & Industries:

  1. May 27, 2025

    Bluebird Bio Beats Investor Suit Over FDA Cancer Warning

    Massachusetts-based biotechnology company Bluebird Bio Inc. has beaten a shareholder suit accusing it of misleading investors about the likelihood of the U.S. Food and Drug Administration's decision requiring a "black box warning" on one of its products due to the cancer risk it posed.

  2. March 29, 2024

    Biotech Co. Inflated Gene Therapy Prospects, Investors Claim

    Massachusetts-based biotechnology company Bluebird Bio Inc. misled investors by understating the safety concerns of a gene therapy for sickle cell, causing damages when stock prices dropped, according to a proposed class action suit filed Thursday in Massachusetts district court.